GB Patent

GB2242134A — Inhalation device

Assigned to Glaxo Group Ltd · Expires 1991-09-25 · 35y expired

What this patent protects

An inhalation device uses a medicament pack (401) wherein at least one container (402) for powdered medicament is defined between two sheets (403, 404) peelably secured to one another. The device comprises means for peeling the sheets apart at an opening station to open the conta…

USPTO Abstract

An inhalation device uses a medicament pack (401) wherein at least one container (402) for powdered medicament is defined between two sheets (403, 404) peelably secured to one another. The device comprises means for peeling the sheets apart at an opening station to open the container; and an outlet (420), communicating with the opened container, through which a user can inhale powdered medicament from the opened container. <IMAGE>

Drugs covered by this patent

Patent Metadata

Patent number
GB2242134A
Jurisdiction
GB
Classification
—
Expires
1991-09-25
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.